Litcius/Paper detail

Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1

Helen Stölting, Laury Baillon, Rebecca Frise, Katie Bonner, Richard Hewitt, Philip L. Molyneaux, Mindy Gore, William Barclay, Sejal Saglani, Clare M. Lloyd

2022Mucosal Immunology41 citationsDOIOpen Access PDF

Abstract

Children are less likely than adults to suffer severe symptoms when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while influenza A H1N1 severity is comparable across ages except for the very young or elderly. Airway epithelial cells play a vital role in the early defence against viruses via their barrier and immune functions. We investigated viral replication and immune responses in SARS-CoV-2-infected bronchial epithelial cells from healthy paediatric (n = 6; 2.5-5.6 years old) and adult (n = 4; 47-63 years old) subjects and compared cellular responses following infection with SARS-CoV-2 or Influenza A H1N1. While infection with either virus triggered robust transcriptional interferon responses, including induction of type I (IFNB1) and type III (IFNL1) interferons, markedly lower levels of interferons and inflammatory proteins (IL-6, IL-8) were released following SARS-CoV-2 compared to H1N1 infection. Only H1N1 infection caused disruption of the epithelial layer. Interestingly, H1N1 infection resulted in sustained upregulation of SARS-CoV-2 entry factors FURIN and NRP1. We did not find any differences in the epithelial response to SARS-CoV-2 infection between paediatric and adult cells. Overall, SARS-CoV-2 had diminished potential to replicate, affect morphology and evoke immune responses in bronchial epithelial cells compared to H1N1.

Topics & Concepts

Immune systemImmunologyInterferonVirusDownregulation and upregulationViral replicationBiologyInfluenza A virusMedicineCoronavirusViral entryVirologyCoronavirus disease 2019 (COVID-19)GeneInternal medicineDiseaseBiochemistryInfectious disease (medical specialty)Respiratory viral infections researchCOVID-19 Clinical Research StudiesInfluenza Virus Research Studies